You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
Australian Public Assessment Report (AusPAR) guidance
Commencing in December 2009, the Therapeutic Goods Administration (TGA) has begun publishing information about its decisions relating to the evaluation of prescription medicines. The information outlines the outcomes of the TGA’s evaluation process, and provides the rationale on which a decision was made to approve or not approve a prescription medicine submission. The information is provided in an Australian Public Assessment Report (AusPAR), which is published on the TGA website. The AusPAR represents a key addition to the regulatory framework for the evaluation of prescription medicines within Australia.
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
This document provides information about the structure, and processes for the compilation, review and publishing of an AusPAR, including guidance on the principles for determining what information is commercially confidential.